Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 15 Aug 2023 for Jazz Pharmaceuticals plc. Read the official filing
Filing timeline
BuySalePeter Gray
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Peter Gray: trading record in brief
Peter Gray, listed as board member, appears in our data through filings on Jazz Pharmaceuticals plc shares, published by SEC (Form 4). Over a trading history stretching from 29 July 2021 to 11 August 2023, the count stands at 5 filings.
Sales make up the whole of the open-market record (1 sale, €177k). Besides market trades, the filings include 3 share grants and 1 option exercise.
On 15 August 2023 came the latest disclosure, a share grant in Jazz Pharmaceuticals plc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter Gray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
3,075 shares0Ordinary SharesSEC:0001765581-23-000080:0
8,000 shares@ US$55.2855.4% of flowOrdinary SharesSEC:0001765581-22-000106:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000086:0
1,414 shares@ US$147.9628.7% of flowOrdinary SharesSEC:0001765581-21-000102:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000071:0
5 of 5 declarations
